Education
About Us
Working with TipRanks
Follow Us
SSY Group Limited (HK:2005)
:2005
2005 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$2.58 - HK$4.67
Previous CloseN/A
Volume3.59M
Average Volume (3M)10.58M
Market Cap
$8.38B
Enterprise ValueHK$11.02B
Total Cash (Recent Filing)$1.29B
Total Debt (Recent Filing)$3.64B
Price to Earnings (P/E)13.3
Beta0.62
Next Earnings
Aug 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 20, 2025Dividend Yield5.91%
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,951,113,300
10 Day Avg. Volume9,699,943
30 Day Avg. Volume10,578,302
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue1.91
Enterprise Value/Gross Profit3.79
Enterprise Value/Ebitda6.34
Forecast
1Y Price Target
$3.50Price Target Upside23.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
SSY Group News
2005 FAQ
What was SSY Group Limited’s price range in the past 12 months?
SSY Group Limited lowest stock price was HK$2.58 and its highest was HK$4.67 in the past 12 months.
What is SSY Group Limited’s market cap?
SSY Group Limited’s market cap is $8.38B.
When is SSY Group Limited’s upcoming earnings report date?
SSY Group Limited’s upcoming earnings report date is Aug 28, 2025 which is 2 days ago.
How were SSY Group Limited’s earnings last quarter?
SSY Group Limited released its earnings results on Mar 28, 2025. The company reported HK$0.127 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.127.
Is SSY Group Limited overvalued?
According to Wall Street analysts SSY Group Limited’s price is currently Undervalued.
Does SSY Group Limited pay dividends?
SSY Group Limited pays a Semiannually dividend of HK$0.095 which represents an annual dividend yield of 5.91%. See more information on SSY Group Limited dividends here
What is SSY Group Limited’s EPS estimate?
SSY Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SSY Group Limited have?
SSY Group Limited has 2,951,113,300 shares outstanding.
What happened to SSY Group Limited’s price movement after its last earnings report?
SSY Group Limited reported an EPS of HK$0.127 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.054%.
Which hedge fund is a major shareholder of SSY Group Limited?
Currently, no hedge funds are holding shares in HK:2005
SSY Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.50 (23.38% Upside)
$3.50 (23.38% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.07%
12-Months-Change
Fundamentals
Return on Equity
9.12%
Trailing 12-Months
Asset Growth
1.39%
Trailing 12-Months
Company Description
SSY Group Limited
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.
Technical Analysis
Sihuan Pharmaceutical Holdings Group
―
Consun Pharmaceutical Group Ltd.
―
Dawnrays Pharmaceutical Holdings Ltd.
―
China Shineway Pharmaceutical Group Limited
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―
Ownership Overview
―
Insiders
2.43%
Mutual Funds
― Other Institutional Investors
95.36% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---